Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug Regimens. | Clin Pharmacol Ther | 2021 | 33135175 | PubTator, text mining | PubMed |
| Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review. | Expert Opin Drug Metab Toxicol | 2021 | 33094670 | PubTator, text mining | PubMed |
| Urine Biomarker Assessment of Infant Adherence to Isoniazid Prophylaxis. | Pediatr Infect Dis J | 2021 | 33055504 | PubTator, text mining | PubMed |
| Multi-biomarker responses to pesticides in an agricultural population from Central Brazil. | Sci Total Environ | 2021 | 32920385 | PubTator, text mining | PubMed |
| Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping. | Clin Pharmacol Ther | 2021 | 32909316 | PubTator, text mining | PubMed |
| Mechanisms of Environment-Induced Autoimmunity. | Annu Rev Pharmacol Toxicol | 2021 | 32857688 | PubTator, text mining | PubMed |
| Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine. | Pharmacogenet Genomics | 2021 | 32815870 | PubTator, text mining | PubMed |
| Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians. | J Allergy Clin Immunol | 2021 | 32791162 | PubTator, text mining | PubMed |
| Mendelian randomisation approaches to the study of prenatal exposures: A systematic review. | Paediatr Perinat Epidemiol | 2021 | 32779786 | PubTator, text mining | PubMed |
| Group-based pharmacogenetic prediction: is it feasible and do current NHS England ethnic classifications provide appropriate data? | Pharmacogenomics J | 2021 | 32683419 | PubTator, text mining | PubMed |
| Validation of the 3D reconstructed human skin Comet assay, an animal-free alternative for following-up positive results from standard in vitro genotoxicity assays. | Mutagenesis | 2021 | 32152633 | PubTator, text mining | PubMed |
| Effect of 2-acetylaminofluorene and its genotoxic metabolites on DNA adduct formation and DNA damage in 3D reconstructed human skin tissue models. | Mutagenesis | 2021 | 31816077 | PubTator, text mining | PubMed |
| Can the personalized medicine approach contribute in controlling tuberculosis in general and India in particular? | Precis Clin Med | 2020 | 35694414 | PubTator, text mining | PubMed |
| Construction of fluorescence active MOFs with symmetrical and conformationally rigid N-2-aryl-triazole ligands. | RSC Adv | 2020 | 35516574 | PubTator, text mining | PubMed |
| Current Perspective: 3D Spheroid Models Utilizing Human-Based Cells for Investigating Metabolism-Dependent Drug-Induced Liver Injury. | Front Med Technol | 2020 | 35047893 | PubTator, text mining | PubMed |
| Enhanced Ionic Accessibility of Flexible MXene Electrodes Produced by Natural Sedimentation. | Nanomicro Lett | 2020 | 34138104 | PubTator, text mining | PubMed |
| The cell cycle regulatory gene polymorphisms TP53 (rs1042522) and MDM2 (rs2279744) in lung cancer: a meta-analysis. | Vavilovskii Zhurnal Genet Selektsii | 2020 | 33959694 | PubTator, text mining | PubMed |
| A Review of Cancer Genetics and Genomics Studies in Africa. | Front Oncol | 2020 | 33659210 | PubTator, text mining | PubMed |
| Biochemical Characterization of Arylamine N-acetyltransferases From Vibrio vulnificus. | Front Microbiol | 2020 | 33537010 | PubTator, text mining | PubMed |
| Validation of PHASE for deriving N-acetyltransferase 2 haplotypes in the Western Cape mixed ancestry population. | Afr J Lab Med | 2020 | 33392048 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=38